Support our work
Decorative header background

A potentially immunologically inert derivative of the reverse tetracycline-controlled transactivator.

Research group Verhaagen
Publication year 2010
Published in Biotechnology Letters
Authors A. Zalmbumbide, S. Weening, S.J. Cramer, M.J. Rabelink, J. Verhaagen, R.C. Hoeben

Support our work!

The Friends Foundation facilitates groundbreaking brain research. You can help us with that.

Support our work